Looks like I will be holding until at least Dec when the stock indexes. Lots of positive info and broker upgrades seen at different sites on internet search. I like it when they recommend that HSO should be a core holding in the health portfolio:
1) Commonwealth Bank initiated coverage of Healthscope Limited with an “overweight” recommendation and $2.55 price target.
2) CIMB initiated coverage on Healthscope with an “add” rating and a $2.75 target price, saying: “We view Healthscope as a core holding."
Read more: http://www.smh.com.au/business/markets/need2know-weak-overseas-lead-20140912-3fem3.html#ixzz3DoU4UJtQ
3)
The positive prognosis for Healthscope shares continues, this time with stockbroker Morgans calling its shares up to $2.75, arguing it is a "core holding".
In a note to clients, it argues the hospital operator has a "developing portfolio of high-return, low-risk assets underpinned by attractive industry dynamics and a defensible reputation for quality and service, helping to support margin expansion, strong cash flow generation and sustainable double-digit earnings growth".
It reckons Healthscope can deliver EBITDA growth of 11.3 per cent per annum and margin expansion of 160bp to 16.9 per cent through FY17, "supported by solid organic growth, infrastructure expansion and ongoing efficiency improvements, with strong cash generation supporting a 70 per cent payout ratio, around 3 per cent yield.
